Sources | Names Used |
---|---|
CTRPv2 | SNX-2112:bortezomib (250:1 mol/mol) |
PharmacoGx | SNX-2112:bortezomib (250:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GMNN | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | SRSF2 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
mRNA | SAFB | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
mRNA | CYBRD1 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | NAA16 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | AGRN | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-06 |
mRNA | EHD2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-06 |
mRNA | HNRNPM | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
mRNA | USP45 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-06 |
mRNA | CNOT9 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |